COVID-19

Nova Leap Health Corp. Announces Execution of Definitive Agreement

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, April 26, 2024…

2 years ago

Biogen Receives Positive CHMP Opinion for TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA®

CHMP positive opinion is based on a robust analytical, non-clinical and clinical data package comparing TOFIDENCE™ to the reference product…

2 years ago

PER PERSON HEALTH CARE SPENDING EXCEEDED $6,700 IN 2022

Between 2018 and 2022, spending increased nearly 19%, average out-of-pocket spending exceeded $860 among people who get insurance through work…

2 years ago

Sensiva Health Partners With PointClickCare On The PCC Marketplace

Sensiva Health has partnered with PointClickCare and has completed a full integration on the PCC Marketplace. ST. ROSE, La., April…

2 years ago

NervGen Engages Russo Partners LLC to Provide Public Relations Services

Vancouver, British Columbia--(Newsfile Corp. - April 25, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"),…

2 years ago

Moderna To Present Respiratory & Cytomegalovirus Research at the ESCMID Global Congress

CAMBRIDGE, MA / ACCESSWIRE / April 25, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will present data…

2 years ago

Biophytis Announces Transfer of ADSs to OTC Market

ADSs delisted from Nasdaq, which will result in meaningful savingsADSs transferred to OTC Pink market; Company will apply to trade…

2 years ago

Moderna and OpenAI Collaborate To Advance mRNA Medicine

Generative AI will help advance Moderna's broad and diverse portfolio to maximize the Company's impact on patientsModerna embeds OpenAI's generative…

2 years ago

CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update

Organizational redesign and rightsizing initiated across company to streamline structures, increase efficiency and reduce operating costsTogether with GSK, ended Pandemic…

2 years ago

CureVac Appoints Thaminda Ramanayake as New Chief Business Officer

Mr. Ramanayake brings more than fifteen years of experience in biopharma company development and deal-makingStrong track record of successful clinical…

2 years ago